UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003226
Receipt number R000003906
Scientific Title Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patients
Date of disclosure of the study information 2010/02/22
Last modified on 2015/02/22 09:13:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patients

Acronym

ROTAS(Risedronate and Osteoporosis Therapy in Aortic valve Stenosis)

Scientific Title

Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patients

Scientific Title:Acronym

ROTAS(Risedronate and Osteoporosis Therapy in Aortic valve Stenosis)

Region

Japan


Condition

Condition

Aortic valve stenosis with osteoporosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of risedronate on the progression of aortic valve stenosis and calcification in patients with osteoporosis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Severity of aortic valve stenosis assessed by echocardiography
Left ventricular mass
Clinical events or symptom

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Treatment with risedronate and alfacalcidol

Interventions/Control_2

Treatment with alfacalcidol

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Female

Key inclusion criteria

1. mild to moderate aortic valve stenosis or calcification on echocardiography without operative indication
2. postmenopausal women
3. patients in whom written informed consent was obtained after a detailed explanation of the study purpose and methods
4. patients who should have medical therapy for osteoporosis based upon 2006 Guideline for the prevention and treatment in patients osteoprosis

Key exclusion criteria

1.rheumatic mitral valve disease
2.patients receiving treatment with oral bisphosphonates
3.congestive heart failure
4.bicuspid aortic valve
5.renal failure(eGFR<30)
6.hepatic dysfunction
7.mild aortic regurgitation, and previous aortic valve surgery
8.patients with hormone recruitment therapy
9.not suitable to this study based upon doctor's judge
10.Abnormalities of the esophagus such a achalasia
11.Known hypersensitivity to any component of this product
12.Hypocalcemia
13.Inability to stand or sit upright for at least 30 minutes after taking the medication
14.patients requiring dental treatment or within 2 month after dental treatment
15.active gastric and duodenal ulcers

Target sample size

180


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masao Daimon

Organization

Juntendo university School of medicine

Division name

The department of cardiology

Zip code


Address

Hongo 2-1-1, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-3111

Email

mdaimon@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masao Daimon

Organization

Juntendo university School of medicine

Division name

The department of cardiology

Zip code


Address

Bunkyo-ku Hongo2-1-1

TEL

03-3813-3111

Homepage URL


Email

mdaimon@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medcine, The department of Cardiology

Institute

Department

Personal name



Funding Source

Organization

Juntendo University School of Medcine, The department of Cardiology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Juntendo University School of Medcine, the department of orthopedic surgery

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 02 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 01 Month 25 Day

Date of IRB


Anticipated trial start date

2010 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry

2015 Year 01 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 02 Month 22 Day

Last modified on

2015 Year 02 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003906


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name